Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease c syndrome
Comorbidity C0032460|polycystic ovary syndrome
Sentences 23
PubMedID- 20807165 Metabolic syndrome in adolescents with polycystic ovary syndrome.
PubMedID- 20852028 Objective: polycystic ovary syndrome (pcos) is associated with the metabolic syndrome.
PubMedID- 20540665 Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions.
PubMedID- 21550088 Both vitamin d deficiency and polycystic ovary syndrome (pcos) are associated with aspects of metabolic syndrome, but it is unclear whether vitamin d deficiency contributes to the metabolic disturbances commonly found in women with pcos.
PubMedID- 21251033 Articles were summarised and grouped according to different sections defining interactions of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease as well as risk factors, pathogenic pathways and treatment options.
PubMedID- 23885694 Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome.
PubMedID- 21450287 Objective: to determine prevalence of metabolic syndrome in adolescents with polycystic ovary syndrome (pcos) and derive features suggestive of propensity for development of metabolic syndrome.
PubMedID- 20396356 [clinical features of the metabolic syndrome in patients with polycystic ovary syndrome].
PubMedID- 22888988 Prevalence of metabolic syndrome in women with polycystic ovary syndrome.
PubMedID- 26488852 Targets to treat metabolic syndrome in polycystic ovary syndrome.
PubMedID- 21956415 Context: polycystic ovary syndrome (pcos) is associated with the metabolic syndrome and, consequently, with a potentially increased risk of cardiovascular disease (cvd) and related mortality later in life.
PubMedID- 23426706 Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome.
PubMedID- 21114431 Background: both non-alcoholic steatohepatitis (nash) and polycystic ovary syndrome (pcos) are associated with metabolic syndrome (ms) and insulin resistance (ir).
PubMedID- 24592034 Objective: to identify biochemical factors that serve as predictors for the metabolic syndrome (mets) in patients with polycystic ovary syndrome (pcos) and to investigate the value of adipocytokines in the prediction of metabolic syndrome.
PubMedID- 21756079 Objective: based on the role of polycystic ovary syndrome as a cause of metabolic syndrome with chronic anovulation, obesity, hyperinsulinemia and hyperandrogenism, development of effective treatment for its obesity is a priority.
PubMedID- 21962027 polycystic ovary syndrome (pcos) is associated with the metabolic syndrome (mets).
PubMedID- 20199774 Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome.
PubMedID- 20925278 [the prevalence of metabolic syndrome in women with polycystic ovary syndrome].
PubMedID- 23656383 Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome.
PubMedID- 22985575 [association of fat distribution with metabolic syndrome in patients with polycystic ovary syndrome].
PubMedID- 22870011 Objective: the aim of the present study was to evaluate the prevalence of metabolic syndrome in women with polycystic ovary syndrome (pcos).
PubMedID- 23283052 Objective: the aim of this study was to assess the association between premicroalbuminuria and metabolic syndrome in women with polycystic ovary syndrome (pcos).
PubMedID- 21277789 Women of reproductive age are not spared from the complications of metabolic syndrome, which overlaps with obesity and polycystic ovary syndrome (pcos), both of which are linked to infertility and poor reproductive outcome.

Page: 1